NDC 70771-1018

Bosentan

Bosentan

Bosentan is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Bosentan.

Product ID70771-1018_045f6a94-0c9b-4970-b962-997b21f18375
NDC70771-1018
Product TypeHuman Prescription Drug
Proprietary NameBosentan
Generic NameBosentan
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-05-01
Marketing CategoryANDA / ANDA
Application NumberANDA207760
Labeler NameCadila Healthcare Limited
Substance NameBOSENTAN
Active Ingredient Strength125 mg/1
Pharm ClassesEndothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70771-1018-1

100 TABLET in 1 BOTTLE (70771-1018-1)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70771-1018-2 [70771101802]

Bosentan TABLET
Marketing CategoryANDA
Application NumberANDA207760
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-01

NDC 70771-1018-1 [70771101801]

Bosentan TABLET
Marketing CategoryANDA
Application NumberANDA207760
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-01

NDC 70771-1018-8 [70771101808]

Bosentan TABLET
Marketing CategoryANDA
Application NumberANDA207760
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-01

NDC 70771-1018-4 [70771101804]

Bosentan TABLET
Marketing CategoryANDA
Application NumberANDA207760
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-01

NDC 70771-1018-5 [70771101805]

Bosentan TABLET
Marketing CategoryANDA
Application NumberANDA207760
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-01

NDC 70771-1018-6 [70771101806]

Bosentan TABLET
Marketing CategoryANDA
Application NumberANDA207760
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
BOSENTAN125 mg/1

Pharmacological Class

  • Endothelin Receptor Antagonist [EPC]
  • Endothelin Receptor Antagonists [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]

NDC Crossover Matching brand name "Bosentan" or generic name "Bosentan"

NDCBrand NameGeneric Name
0054-0520BosentanBosentan
0054-0521BosentanBosentan
0591-2511bosentanbosentan
0591-2512bosentanbosentan
10148-125bosentanbosentan
10148-625bosentanbosentan
46708-383BosentanBosentan
46708-384BosentanBosentan
47335-038BosentanBosentan
47335-039BosentanBosentan
47781-270BosentanBosentan
47781-271BosentanBosentan
49884-058BosentanBosentan
49884-059BosentanBosentan
62332-383BosentanBosentan
62332-384BosentanBosentan
65162-873BosentanBosentan
65162-874BosentanBosentan
69097-377BOSENTANBOSENTAN
69097-378BOSENTANBOSENTAN
68382-446BosentanBosentan
68382-447BosentanBosentan
70771-1017BosentanBosentan
70771-1018BosentanBosentan
68180-387BosentanBosentan
68180-386BosentanBosentan
66215-101Tracleerbosentan

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.